Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 55 | 53 |
| Accounts receivable | 27 | -35 |
| Other Working Capital | 14 | 75 |
| Other Operating Activity | -494 | -342 |
| Operating Cash Flow | $-398 | $-248 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -37 | -13 |
| Other Investing Activity | -16 | 0 |
| Investing Cash Flow | $-54 | $-13 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | -78 | 6,195 |
| Other Financing Activity | 16 | -1 |
| Financing Cash Flow | $-62 | $6,194 |
| Beginning Cash Position | 6,282 | 350 |
| End Cash Position | 5,765 | 6,282 |
| Net Cash Flow | $-513 | $5,933 |
| Free Cash Flow | ||
| Operating Cash Flow | -398 | -248 |
| Capital Expenditure | -37 | -13 |
| Free Cash Flow | -435 | -261 |